Sanofi (NASDAQ:SNY) has stopped shipping its anti-cholesterol therapy Praluent, developed with Regeneron (NASDAQ:REGN), as ...

Sanofi said on Tuesday it had stopped supplying Praluent, a popular cholesterol drug jointly developed by the French ...

Sanofi is pulling its PCSK9 drug Praluent from the Chinese market. President Donald Trump said U.S. pharmaceutical tariffs ...

Sanofi (NASDAQ:SNY) announced on Tuesday that it has stopped supplying Praluent in China due to limited availability of the popular cholesterol medication.

Praluent-treated patients started the trial on 75 mg every 2 weeks, and switched to 150 mg every 2 weeks if their LDL-C levels remained above 50 mg/dL (n=2,615).

Praluent and a similar drug, Amgen's Repatha, work in a different way and lower cholesterol much more. Patients give themselves shots of the medicine once or twice a month.

The second issue is your very low LDL level, and the data for LDL levels is firmly on the side of the cardiologists you spoke with. The lower the LDL, the lower the risk of heart disease, and levels ...

Praluent is supplied in 2 dosage strengths, 75mg/mL and 150mg/mL, in a single-dose prefilled pen. In children aged 8 to 11 years, Praluent should be given by a caregiver following proper training.

Praluent can be administered without regard to the timing of apheresis. The dosing recommendation was based on data from a double-blind, placebo-controlled study conducted in 62 patients with HeFH ...

UnitedHealth Group Inc. UNH 0.32% said Friday that Praluent, developed by Regeneron Pharmaceuticals Inc. REGN -0.07% and Sanofi SA, SAN 0.99% will be the preferred drug for a new class of ...

Praluent-treated patients started the trial on 75 mg every 2 weeks, and switched to 150 mg every 2 weeks if their LDL-C levels remained above 50 mg/dL (n=2,615).